These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 10555154)

  • 1. Oligonucleotide facilitators enhance the catalytic activity of RNA-cleaving DNA enzymes.
    Horn S; Schwenzer B
    Antisense Nucleic Acid Drug Dev; 1999 Oct; 9(5):465-72. PubMed ID: 10555154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oligonucleotide facilitators enable a hammerhead ribozyme to cleave long RNA substrates with multiple-turnover activity.
    Jankowsky E; Schwenzer B
    Eur J Biochem; 1998 May; 254(1):129-34. PubMed ID: 9652405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficient improvement of hammerhead ribozyme mediated cleavage of long substrates by oligonucleotide facilitators.
    Jankowsky E; Schwenzer B
    Biochemistry; 1996 Dec; 35(48):15313-21. PubMed ID: 8952482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oligonucleotide facilitators may inhibit or activate a hammerhead ribozyme.
    Jankowsky E; Schwenzer B
    Nucleic Acids Res; 1996 Feb; 24(3):423-9. PubMed ID: 8602353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peptide nucleic acid (PNA) is capable of enhancing hammerhead ribozyme activity with long but not with short RNA substrates.
    Jankowsky E; Strunk G; Schwenzer B
    Nucleic Acids Res; 1997 Jul; 25(14):2690-3. PubMed ID: 9207013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A general approach for the use of oligonucleotide effectors to regulate the catalysis of RNA-cleaving ribozymes and DNAzymes.
    Wang DY; Lai BH; Feldman AR; Sen D
    Nucleic Acids Res; 2002 Apr; 30(8):1735-42. PubMed ID: 11937626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A DNA metalloenzyme with DNA ligase activity.
    Cuenoud B; Szostak JW
    Nature; 1995 Jun; 375(6532):611-4. PubMed ID: 7791880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acquisition of novel catalytic activity by the M1 RNA ribozyme: the cost of molecular adaptation.
    Cole KB; Dorit RL
    J Mol Biol; 1999 Oct; 292(4):931-44. PubMed ID: 10525416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of ribozyme catalytic activity by a contiguous oligodeoxynucleotide (facilitator) and by 2'-O-methylation.
    Goodchild J
    Nucleic Acids Res; 1992 Sep; 20(17):4607-12. PubMed ID: 1383929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel mode of regulation of an RNA-cleaving DNAzyme by effectors that bind to both enzyme and substrate.
    Wang DY; Sen D
    J Mol Biol; 2001 Jul; 310(4):723-34. PubMed ID: 11453683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A general strategy for effector-mediated control of RNA-cleaving ribozymes and DNA enzymes.
    Wang DY; Lai BH; Sen D
    J Mol Biol; 2002 Apr; 318(1):33-43. PubMed ID: 12054766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new and efficient DNA enzyme for the sequence-specific cleavage of RNA.
    Feldman AR; Sen D
    J Mol Biol; 2001 Oct; 313(2):283-94. PubMed ID: 11800557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of activities between hammerhead ribozymes and DNA enzymes targeted to L6 BCR-ABL chimeric (b2a2) mRNA.
    Warashina M; Kuwabara T; Taira K
    Nucleic Acids Symp Ser; 1997; (37):213-4. PubMed ID: 9586075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding affinity and specificity of Escherichia coli RNase H1: impact on the kinetics of catalysis of antisense oligonucleotide-RNA hybrids.
    Lima WF; Crooke ST
    Biochemistry; 1997 Jan; 36(2):390-8. PubMed ID: 9003192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Further studies on the use of oligonucleotide facilitators to increase ribozyme turnover.
    Nesbitt S; Goodchild J
    Antisense Res Dev; 1994; 4(4):243-9. PubMed ID: 7537560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization and divalent metal-ion dependence of in vitro selected deoxyribozymes which cleave DNA/RNA chimeric oligonucleotides.
    Faulhammer D; Famulok M
    J Mol Biol; 1997 Jun; 269(2):188-202. PubMed ID: 9191064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substitution of non-catalytic stem and loop regions of hammerhead ribozyme with DNA counterparts only increases KM without sacrificing the catalytic step (kcat): a way to improve substrate-specificity.
    Shimayama T; Sawata S; Komiyama M; Takagi Y; Tanaka Y; Wada A; Sugimoto N; Rossi JJ; Nishikawa F; Nishikawa S
    Nucleic Acids Symp Ser; 1992; (27):17-8. PubMed ID: 1283905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Catalytic nucleic acids: from lab to applications.
    Sun LQ; Cairns MJ; Saravolac EG; Baker A; Gerlach WL
    Pharmacol Rev; 2000 Sep; 52(3):325-47. PubMed ID: 10977866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A core folding model for catalysis by the hammerhead ribozyme accounts for its extraordinary sensitivity to abasic mutations.
    Peracchi A; Karpeisky A; Maloney L; Beigelman L; Herschlag D
    Biochemistry; 1998 Oct; 37(42):14765-75. PubMed ID: 9778351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RNA-cleaving DNA enzymes with altered regio- or enantioselectivity.
    Ordoukhanian P; Joyce GF
    J Am Chem Soc; 2002 Oct; 124(42):12499-506. PubMed ID: 12381192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.